drug
as of 2026-07-01ACP-104
at a glance
small molecule
Pre-approval / investigational in the US
Developed by University of Texas Southwestern Medical Center
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
2
ACP-104 in Acutely Psychotic Subjects With Schizophrenia
NCT00490516Phase 2Completed
Safety Study of ACP-104: To Demonstrate the Safety, Tolerability, and Pharmacokinetics
NCT00628420Phase 1Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication